Parichehr Pasbakhsh

Dr. Parichehr Pasbakhsh


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2021 in Journal of Chemical Neuroanatomy
Verified
Journal Article
Closed access
DZDavood Zarini
Davood Zarini
PPParichehr Pasbakhsh
Parichehr Pasbakhsh
SNSaeid Nekoonam
Saeid Nekoonam
SMSina Mojaverrostami
Sina Mojaverrostami
SGSoudabeh Ghasemi
Soudabeh Ghasemi
IKIraj Ragerdi Kashani
Iraj Ragerdi Kashani

24 February 2024 in Molecular Biology Reports
Verified
Journal Article
Closed access
PDF file
MNMehrazin Noshadian
Mehrazin Noshadian
IKIraj Ragerdi Kashani
Iraj Ragerdi Kashani
RAReza Asadi-Golshan
Reza Asadi-Golshan
DZDavood Zarini
Davood Zarini
NGNeda Ghafari
Neda Ghafari
PPParichehr Pasbakhsh
Parichehr Pasbakhsh


29 October 2021 in Journal of Cardiothoracic Surgery
Verified
Journal Article
Open access
PDF file
AZArezou Zoroufian
Arezou Zoroufian
RMReza Mohseni-Badalabadi
Reza Mohseni-Badalabadi
MMMehrdad Mahalleh
Mehrdad Mahalleh
SGSeyyed Mojtaba Ghorashi
Seyyed Mojtaba Ghorashi
PPParichehr Pasbakhsh
Parichehr Pasbakhsh
NONegar Omidi
Negar Omidi
Background: The clinical manifestations of coronavirus disease 2019 (COVID-19) overlap with those of other disorders, especially cardiovascular disease. Case presentation: We herein describe a 58-year-old woman who presented with syncopal episodes and dyspnea on exertion with a left atrial (LA) mass, scheduled for surgical removal and mitral valve replacement. Nearly 3 months later, the patient developed dyspnea, fever, and a sore throat, resulting in hospital admission with suspected COVID-19. During the diagnostic evaluation, a larger LA mass was detected. The mass seemed to be a COVID-19–induced organized thrombus with prosthetic mitral valve malfunction. Resection was, therefore, planned. An immunohistochemistry study revealed a liposarcoma. Conclusions: The unusual early recurrence of liposarcomas and the misdiagnosis with COVID-19–induced thrombosis are the hallmark of the present case.

18 February 2026 in PLOS ONE
Verified
Journal Article
Open access
HAHoda Akbari
Hoda Akbari
IRIraj Ragerdi-Kashani
Iraj Ragerdi-Kashani
FRFarzaneh Rezaei-Yazdi
Farzaneh Rezaei-Yazdi
PPParichehr Pasbakhsh
Parichehr Pasbakhsh
Introduction: Multiple sclerosis is a chronic demyelinating disease of the central nervous system. Transplantation of oligodendrocyte progenitor cells (OPCs) is a promising approach to enhance remyelination; however, the influence of the OPCs’ microenvironmental origin on their therapeutic efficacy remains unclear. This study compared the remyelinating capacity of OPCs isolated from inflammatory (lipopolysaccharide) and non-inflammatory (cuprizone) microenvironments after transplanting into the corpus callosum and examined their effects on extracellular matrix chondroitin sulfate proteoglycans (CSPGs). Methods: OPCs were isolated from two microenvironments and characterized by immunocytochemistry and RT-qPCR. After transplanting, OPC homing, remyelination, gene expression, and CSPG levels were evaluated using DiI labeling, LFB staining, RT-qPCR, and immunofluorescence, respectively. Results: Severe demyelination exhibited in the cuprizone group compared with healthy controls (p < 0.001) by Luxol fast blue staining. Myelin content significantly increased in both transplating OPCs groups (p < 0.001), with a higher impact observed in mice received OPCs isolated from cuprizone as compared with lipopolysaccharide (p < 0.001). Also, RT-qPCR analysis exhibited significantly reduced MBP expression in the cuprizone group, whereas was significantly increased after OPC transplantation, particularly in the cuprizone-derived OPC group (p < 0.001), whereas a lower increased with lipopolysaccharide-derived OPCs (p < 0.01). MOG expression exhibited a same pattern, with a significantly increase in the cuprizone-derived OPC group compared with both the cuprizone and lipopolysaccharide-derived OPC groups (p < 0.001). Additionally, Immunofluorescence analysis exhibited increasing CSPG4 levels in the cuprizone group, but significantly reduced after OPC transplantation (p < 0.001). Notably, in the cuprizone-derived OPC group higher reduction of CSPG4 levels observed compare with in the lipopolysaccharide-derived OPC group (p < 0.001). Conclusion: OPC transplantation improves remyelination and reduces the CSPG level, but the effectiveness is more related to the previous history of the OPC isolation microenvironment and the new donor.

10 July 2025 in Bratislava Medical Journal
Verified
Journal Article
Closed access
PDF file
SAShiva Amirizadeh
Shiva Amirizadeh
IKIraj Ragerdi Kashani
Iraj Ragerdi Kashani
RAReza Asadi-Golshan
Reza Asadi-Golshan
MHMaedeh Hashemi
Maedeh Hashemi
DZDavood Zarini
Davood Zarini
PPParichehr Pasbakhsh
Parichehr Pasbakhsh